Literature DB >> 29136537

New advances in understanding the host immune response to Pneumocystis.

J Claire Hoving1, Jay K Kolls2.   

Abstract

Pneumocystis jirovecii causes clinical pneumonia in immunocompromised hosts. Despite this, the inability to cultivate this organism in vitro has likely hindered the field in ascertaining the true impact of Pneumocystis in human infection. However the recent release of the genome as well as in advances in understanding host genetics, and other risk factors for infection and robust experimental models of disease have shed new light on the impact of this fungal pathogen as to better define populations at risk. This review will highlight these recent advances as well as highlight future needed areas of research.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 29136537      PMCID： PMC5733705          DOI： 10.1016/j.mib.2017.10.019

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN： 1369-5274            Impact factor:   7.934


  46 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Pneumocystis jiroveci infection in patients with hyper-immunoglobulin E syndrome.

Authors:  Alexandra F Freeman; Joie Davis; Victoria L Anderson; William Barson; Dirk N Darnell; Jennifer M Puck; Steven M Holland
Journal:  Pediatrics       Date:  2006-08-28       Impact factor: 7.124

3.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

4.  Interaction of Pneumocystis carinii with dendritic cells and resulting host responses to P. carinii.

Authors:  Hiroyasu Kobayashi; Stefan Worgall; Timothy P O'Connor; Ronald G Crystal
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

5.  Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity.

Authors:  Taylor Eddens; Waleed Elsegeiny; Maria de la Luz Garcia-Hernadez; Patricia Castillo; Giraldina Trevejo-Nunez; Katelin Serody; Brian T Campfield; Shabaana A Khader; Kong Chen; Javier Rangel-Moreno; Jay K Kolls
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

6.  Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses.

Authors:  B A Garvy; J A Wiley; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study.

Authors:  Matthew W Fei; Catherine A Sant; Eunice J Kim; Alexandra Swartzman; J Lucian Davis; Leah G Jarlsberg; Laurence Huang
Journal:  Scand J Infect Dis       Date:  2009

8.  Fungal colonization with Pneumocystis correlates to increasing chloride channel accessory 1 (hCLCA1) suggesting a pathway for up-regulation of airway mucus responses, in infant lungs.

Authors:  Francisco J Pérez; Carolina A Ponce; Diego A Rojas; Pablo A Iturra; Rebeca I Bustamante; Myriam Gallo; Karime Hananias; Sergio L Vargas
Journal:  Results Immunol       Date:  2014-07-30

9.  Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients.

Authors:  Maria L Calero-Bernal; Isabel Martin-Garrido; Mikel Donazar-Ezcurra; Andrew H Limper; Eva M Carmona
Journal:  Can Respir J       Date:  2016-09-18       Impact factor: 2.409

10.  Increasing Pneumocystis pneumonia, England, UK, 2000-2010.

Authors:  Rishma Maini; Katherine L Henderson; Elizabeth A Sheridan; Theresa Lamagni; Gordon Nichols; Valerie Delpech; Nick Phin
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883
View more
  11 in total

1.  Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors.

Authors:  Marissa A Zarakas; Jigar V Desai; Georgios Chamilos; Michail S Lionakis
Journal:  Curr Fungal Infect Rep       Date:  2019-07-05

2.  Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome.

Authors:  Ji Eun Kim; Ahram Han; Hajeong Lee; Jongwon Ha; Yon Su Kim; Seung Seok Han
Journal:  BMC Nephrol       Date:  2019-06-10       Impact factor: 2.388

3.  Interstitial pneumonia in immunocompetent laboratory rats caused by natural infection with Pneumocystis carinii.

Authors:  Masahiko Yasuda; Ritsuki Uchida; Yoko Kamai; Hanako Morita; Mai Tanaka; Tomoko Ishida; Misa Mochizuki; Masafumi Yamamoto; Nobuhito Hayashimoto; Kenji Kawai
Journal:  Exp Anim       Date:  2021-09-13

4.  Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Pneumocystis Infection.

Authors:  Dan Ma; Qian-Yu Zhang; Heng-Mo Rong; Kan Zhai; Zhao-Hui Tong
Journal:  J Immunol Res       Date:  2022-04-14       Impact factor: 4.493

Review 5.  Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients.

Authors:  Mohamed Nasr; Amad Mohammad; Mosab Hor; Ahmed M Baradeiya; Hodan Qasim
Journal:  Cureus       Date:  2022-08-06

Review 6.  Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

Authors:  Emilie Corvilain; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2018-08-22       Impact factor: 8.317

7.  OMIP-080: 29-Color flow cytometry panel for comprehensive evaluation of NK and T cells reconstitution after hematopoietic stem cells transplantation.

Authors:  Sarka Vanikova; Abhishek Koladiya; Jan Musil
Journal:  Cytometry A       Date:  2021-10-24       Impact factor: 4.714

8.  Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.

Authors:  Nan-Nan Zhang; Xu Huang; Hui-Ying Feng; Lin-Na Huang; Jin-Gen Xia; Yan Wang; Yi Zhang; Xiao-Jing Wu; Min Li; Wei Cui; Qing-Yuan Zhan
Journal:  Int J Med Sci       Date:  2019-08-14       Impact factor: 3.738

9.  X-linked CD40 ligand deficiency in a 1-year-old male Shih Tzu with secondary Pneumocystis pneumonia.

Authors:  Kristen Merrill; Emily Coffey; Eva Furrow; Isabelle Masseau; Hansjörg Rindt; Carol Reinero
Journal:  J Vet Intern Med       Date:  2020-12-04       Impact factor: 3.175

10.  Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation.

Authors:  Luis Fonte; María Ginori; Enrique J Calderón; Yaxsier de Armas
Journal:  J Fungi (Basel)       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.